25 studies on CJC-1295 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This review highlights a critical distinction for peptide users and clinicians: only GLP-1R agonists currently possess reproducible, high-quality evidence for a specific musculoskeletal indication (knee osteoarthritis…
This research provides crucial analytical standards and degradation profiles that can significantly enhance anti-doping detection capabilities. By understanding how these peptides break down, forensic laboratories can…
This research is profoundly significant as it provides a robust proof-of-concept for creating long-acting peptide therapeutics through the innovative strategy of albumin bioconjugation. The identification of CJC-1295 …
This study conclusively demonstrates the efficacy of CJC-1295 as a potent, long-acting stimulator of the GH/IGF-1 axis, offering a significant advancement over traditional GHRH therapies. Its ability to provide sustai…
This study demonstrates that CJC-1295 is a highly effective long-acting GHRH analog capable of restoring normal growth in a severe model of GHRH deficiency. The ability to achieve significant growth normalization with…
This finding is profoundly significant because the preservation of GH pulsatility is believed to be critical for its optimal physiological actions, including metabolic regulation and tissue growth. Disrupting this nat…
These findings provide a deeper understanding of the systemic effects of GH/IGF-1 axis activation beyond just GH and IGF-1 levels, revealing a complex interplay with various physiological pathways. The observed change…
The identification of CJC-1295 in an illicit preparation highlights the ongoing challenge of unregulated peptide drug availability and use, particularly within communities like bodybuilding. As a growth hormone-releas…
This groundbreaking analytical method represents a major leap forward in anti-doping science, providing a powerful tool to combat the illicit use of peptide hormones in sports. By significantly enhancing the ability t…
This expanded test method represents a significant leap forward in the analytical capabilities for large peptides, offering unprecedented sensitivity and specificity. The ability to accurately detect peptides >2 kDa a…
This study highlights the significant online presence and self-directed use of performance-enhancing peptides like CJC-1295 among women, often outside medical supervision. Understanding these online communities provid…
This innovative method represents a significant advancement in the analytical detection of GHRHs, offering unprecedented specificity for their identification in human plasma. This capability is particularly crucial fo…
This highly sensitive IPCR method represents a significant advancement in equine anti-doping efforts. The ability to detect GHRH analogs like CJC-1295 at extremely low concentrations and over an extended period will m…
This groundbreaking method provides a definitive and highly sensitive tool for anti-doping agencies to confirm the illicit use of CJC-1295 in equestrian sports. The ability to detect conjugated CJC-1295, which has a p…
This research provides a critical advancement in the analytical methodology for GHRH detection, paving the way for more accurate and sensitive measurements in various applications. The optimized immunopurification str…
This study represents a significant advancement in the fight against doping in sports, specifically targeting growth hormone releasing hormone synthetic analogs. By identifying and characterizing previously unknown me…
This novel antibody-free ultrafiltration-based nanoLC-HRMS/MS assay represents a significant advancement in the field of analytical toxicology and anti-doping science. The ability to detect GHRHs at such low pg/mL con…
This study provides a highly sensitive and specific analytical tool that can significantly enhance anti-doping efforts by closing a critical detection gap for mid-sized peptidic drugs. The improved sensitivity means t…
This advanced analytical method represents a significant leap forward in the detection of GHRHs, offering unprecedented sensitivity and reliability for anti-doping laboratories. Its robust performance could greatly en…
This research represents a significant leap forward in anti-doping science, providing a powerful new tool to detect a previously challenging class of performance-enhancing peptides. By closing a critical detection gap…
This highly sensitive and robust nano LC-Q/Orbitrap MS method represents a significant advancement in the detection of GHRH and its analogs, which are frequently abused performance-enhancing drugs. The enhanced sensit…
This hypothetical study highlights CJC-1295's potential as a long-acting growth hormone-releasing hormone (GHRH) analog, capable of providing sustained GH and IGF-1 elevation from a single dose. This sustained release…
The premature termination of this Phase 2 study signifies that the potential of CJC 1295 as a viable treatment for HIV-associated visceral obesity remains entirely unconfirmed and unexplored through the completion of …
The widespread and increasing misuse of peptides poses a significant threat to the integrity of sports and the long-term health of athletes. This comprehensive review provides crucial insights for anti-doping organiza…